Real Time Metabolic Imaging to Interrogate Early Detection and Prevention of Pancreatic Cancer

实时代谢成像探讨胰腺癌的早期检测和预防

• 批准号: 10744576
• 负责人: Jose S Enriquez
• 金额: $ 3.72万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-01 至 2025-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10744576
• 关键词: Alanine; Anatomy; Animal Model; Animals; Area; Biochemical; Biological Markers; Biology; Cancer Center; Cancer Detection; Cancer Etiology; Cessation of life; Clinical; Contrast Media; Cyst; Data Analyses; Detection; Development; Diagnosis; Disease; Disease Progression; Doctor of Medicine; Doctor of Philosophy; Early Diagnosis; Educational process of instructing; Fellowship; Future; Genetic Models; Genetically Engineered Mouse; Genomics; Goals; Histological Techniques; Image; Imaging Techniques; Immunoprevention; Immunotherapy; Indolent; Inflammation; Institution; Laboratories; Learning; Lesion; Magnetic Resonance Imaging; Malignant Neoplasms; Malignant neoplasm of pancreas; Measures; Mentors; Metabolic; Metabolism; Methodology; Methods; Modality; Modeling; Monitor; Morphology; Non-Invasive Detection; Pancreas; Pancreatic Ductal Adenocarcinoma; Pancreatic Intraepithelial Neoplasia; Pattern; Phase; Positron-Emission Tomography; Postdoctoral Fellow; Prevalence; Prevention; Prevention Measures; Prevention strategy; Production; Public Speaking; Pyruvate; Recommendation; Research; Research Project Grants; Research Proposals; Scientist; Sensitivity and Specificity; Signal Transduction; Specificity; Survival Rate; Symptoms; Techniques; Time; Tissues; Training; Translating; United States; Warburg Effect; Work; Writing; cancer imaging; cancer prevention; cancer type; chronic pancreatitis; detection method; efficacy evaluation; efficacy testing; extracellular; high risk; human subject; imaging approach; imaging modality; imaging system; in vivo; in vivo imaging; innovation; metabolic imaging; metabolomics; molecular imaging; mouse model; neoplastic; non-invasive imaging; non-invasive monitor; novel; overtreatment; pancreatic cancer model; pancreatic ductal adenocarcinoma model; pre-clinical; premalignant; prevent; skills; specific biomarkers; success; tool; transcriptomics; tumor; tumor microenvironment

Project Summary Pancreatic ductal adenocarcinoma (PDAC) has a median 5-year survival of only 11%, and early diagnosis of PDAC is recognized as one of the highest priority areas by the NCI, with a focus on identification of more sensitive and specific biomarkers and imaging strategies in discernible preneoplastic lesions. The overarching goal of this proposal is to develop the capability of non-invasively detecting advanced pancreatic intraepithelial neoplasia (PanIN) precursor lesions in pancreas prior to invasive disease in human subjects using two magnetic resonance imaging-based tools: a) hyperpolarized metabolic imaging (HP MR) and b) acidoCEST MRI. Hyperpolarization increases the signal of conventional MRI by over 10,000-fold. AcidoCEST MRI uses a clinically approved contrast agent to quantitatively measure the extracellular pH (pHe) in the tumor microenvironment. The application of dual acidoCEST and HP MR is innovative as they interrogate two different but related biochemical features of PanINs: extracellular pH (pHe) and dynamic metabolic flux (HP lactate-to- pyruvate and HP alanine-to-pyruvate ratios), respectively. Together, this approach provides an exciting opportunity to identify and understand early metabolic aberrations and biomarkers associated with these early lesions, to enable detection of advanced pancreatic preneoplastic lesions as well as pancreatic cancer at the smallest size, for which no methods of detection currently exist. This is a transitional research proposal with multiple sponsors for the F99 phase. Including the laboratories of Pratip Bhattacharya, Ph.D. in the Department of Cancer Systems Imaging and Florencia McAllister, M.D. in the Department of Clinical Cancer Prevention, both at MD Anderson Cancer Center with the following two aims. Aim 1, the F99 phase, is to demonstrate and validate the sensitivity and specificity of dynamic hyperpolarized metabolic biomarkers in the detection and monitoring the progression of pancreatic premalignant lesions to PDAC and compare these to a chronic pancreatitis model. Aim 2, the K00 phase research direction, is to demonstrate detection of PanIN with a combination of HP MR and acidoCEST and to determine the efficacy of immunoprevention on PanIN models. The success of this proposal has the potential for leading to practice changing recommendations for non-invasively detecting and monitoring advanced PanIN lesions and incipient pancreatic cancer, as well as to non-invasively assess the immunopreventive measures for cancer prevention. Also included in this proposal is a fellowship training plan to be conducted in both the F99 and K00 phases. They include additional training in metabolomic data analysis, research skills in small animal handling, histological and imaging techniques, public speaking, and scientific writing during the F99 phase. For the K00 phase the training plan include establishing dual-imaging modalities, develop immunopreventative strategies, mentoring and teaching future scientists, and inter-departmental or institutional networking.

项目摘要 胰腺导管腺癌(PDAC)的中位5年生存率仅为11%，早期 PDAC的诊断被NCI认为是最优先的领域之一，重点是识别 在可辨别的癌前病变中，更敏感和特异的生物标志物和成像策略。这个 这项建议的首要目标是发展非侵入性检测晚期胰腺的能力。 人类侵袭性疾病前胰腺上皮内瘤变(Panin)前驱病变的研究 两种基于磁共振成像的工具：a)超极化代谢成像(HP MR)和b)acidoCEST 核磁共振检查。超极化使常规核磁共振的信号增加了一万倍以上。AcidoCEST MRI使用 临床批准的造影剂定量测量肿瘤细胞外pH(Phe) 微环境。Dual AidoCEST和HP MR的应用具有创新性，因为它们询问了两种不同的 但与PAINS相关的生化特征：胞外pH(Phe)和动态代谢通量(HP乳酸到... 丙酮酸和HP丙氨酸与丙酮酸的比率)。总而言之，这种方法提供了一个令人兴奋的 识别和了解早期代谢异常和与这些早期代谢异常相关的生物标记物的机会 病变，以便能够检测晚期胰腺癌前病变以及胰腺癌 最小的大小，目前还没有检测方法。 这是一个过渡性的研究提案，F99阶段有多个赞助商。包括 Patip Bhattacharya实验室，癌症系统成像和弗洛伦西亚系博士 麦卡利斯特，医学博士，临床癌症预防部门，两人都在MD安德森癌症中心 遵循两个目标。目标1，F99阶段，是演示和验证动态的敏感性和特异性 超极化代谢生物标志物在检测和监测胰腺癌前病变进展中的作用 并将其与慢性胰腺炎模型进行比较。目标2，K00阶段研究方向， 目的是演示HP MR和acidoCEST联合检测Panin，并确定其疗效 在Panin模型上的免疫预防。这一提议的成功有可能导致实践 改变非侵入性检测和监测晚期PAIN病变和早期病变的建议 并对预防癌症的免疫预防措施进行非侵入性评估。 该提案还包括一项将在F99和K00进行的奖学金培训计划 阶段。它们包括代谢数据分析方面的额外培训，小动物处理方面的研究技能， F99阶段的组织学和成像技术、公共演讲和科学写作。对于K00 分阶段培训计划包括建立双重成像模式，制定免疫预防策略， 指导和教授未来的科学家，以及跨部门或机构网络。